Results for tag: "Biologics Outsourcing"

The biologics outsourcing market is a subset of the pharmaceutical manufacturing industry, focusing on the production of biologics. Biologics are complex molecules derived from living organisms, such as proteins, antibodies, and vaccines. These molecules are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. As biologics become increasingly important in the treatment of these diseases, the demand for biologics outsourcing has grown. Biologics outsourcing involves the transfer of biologics production from the pharmaceutical company to a third-party manufacturer. This allows the pharmaceutical company to focus on the development and marketing of their products, while the third-party manufacturer handles the production. This arrangement also allows the pharmaceutical company to access the latest technologies and expertise in biologics production. Companies in the biologics outsourcing market include Lonza, Boehringer Ingelheim, Merck KGaA, and Fujifilm Diosynth Biotechnologies. Show Less Read more